A practical, patient-first guide to reading stool inflammation results without jumping straight to the worst-case scenario.
- Fecal calprotectin normal range is usually below 50 µg/g in adults, though some laboratories use below 100 µg/g as reassuring.
- Borderline fecal calprotectin between 50 and 150 µg/g often needs a repeat test rather than an immediate colonoscopy if there are no red flags.
- High fecal calprotectin above 250 µg/g makes intestinal inflammation more likely, especially with bleeding, anemia, weight loss, or night-time diarrhea.
- IBS usually has normal calprotectin; a value below 50 µg/g strongly supports a non-inflammatory pattern in adults with typical IBS symptoms.
- Infection can raise calprotectin for 2 to 6 weeks after gastroenteritis, so timing matters before interpreting a single result.
- NSAIDs can elevate calprotectin; ibuprofen, naproxen, and diclofenac may irritate the intestinal lining and create a false IBD signal.
- Repeat testing is often reasonable after 2 to 4 weeks for borderline results, or 4 to 6 weeks after a clear infection has settled.
- Colonoscopy discussion makes sense with persistent values above 250 µg/g, visible blood, low hemoglobin, raised CRP, low albumin, or symptoms waking you at night.
What a normal fecal calprotectin result usually means
A typical adult fecal calprotectin normal range is below 50 µg/g of stool; values below this level make active inflammatory bowel disease less likely, not impossible. As of June 7, 2026, most UK and European pathways treat 50 to 150 µg/g as a grey zone and values above 250 µg/g as a stronger inflammation signal.
I’m Thomas Klein, MD, and in clinic I explain this test as a smoke alarm, not a diagnosis. A normal fecal calprotectin test does not prove IBS, but in an adult with cramping, bloating, and alternating bowel habits, a result under 50 µg/g is a strong reason to avoid panic and review the pattern calmly.
Calprotectin is a protein released mainly by neutrophils, the immune cells that arrive when the intestinal lining is irritated or inflamed. The NICE DG11 pathway supports using fecal calprotectin to help separate likely IBD from IBS in adults with new lower-gut symptoms when bowel cancer is not the main concern (National Institute for Health and Care Excellence, 2013).
Kantesti is an AI blood test interpretation platform that helps patients place gut symptoms beside CBC, CRP, ferritin, albumin, liver enzymes, and other blood markers rather than reading one stool number in isolation. Our clinical governance and company background are described on our About Us page for readers who want to know who is behind the medical content.
Why laboratories use different calprotectin cutoffs
Fecal calprotectin cutoffs differ because assays, extraction methods, age groups, and local referral pathways are not identical. A result of 80 µg/g may be flagged high by one laboratory and borderline by another, so the printed reference interval matters as much as the number.
Units can also confuse people. Most reports use µg/g, but some older systems use mg/kg; 50 µg/g equals 50 mg/kg, so a unit change should not be mistaken for a tenfold jump.
Some European laboratories use under 50 µg/g as normal, 50 to 100 µg/g as indeterminate, and above 100 µg/g as abnormal. Others avoid acting until 150 or 200 µg/g, especially in primary care pathways where false positives can send too many low-risk patients for invasive testing.
This is the same problem patients face with many lab reference intervals: the word high can reflect local statistics, not a diagnosis. For a broader explanation of why ranges can mislead, our guide to blood test normal range is useful even though calprotectin is measured in stool.
Kantesti AI reads blood biomarkers against age, sex, units, and clinical context; our biomarkers guide explains why the same numeric value can carry different meaning in different people. Calprotectin deserves that same contextual thinking.
How high fecal calprotectin changes the probability of IBD
A high fecal calprotectin result above 250 µg/g raises the probability of intestinal inflammation, especially Crohn’s disease or ulcerative colitis, but it does not diagnose either condition. Values above 500 µg/g are more concerning, and results above 1000 µg/g often occur in severe colitis or significant infection.
The jump from 60 to 120 µg/g is not the same clinical event as a jump from 300 to 900 µg/g. In my experience, a mildly raised value often sends people down internet rabbit holes, while the larger and persistent rises are the ones that more often match colonoscopy findings.
Van Rheenen and colleagues reported in BMJ that fecal calprotectin is useful for screening patients with suspected IBD because low values substantially reduce the chance of IBD, while positive results still need clinical confirmation (van Rheenen et al., 2010). That distinction matters: the test is better at ruling out inflammation than proving the exact cause of inflammation.
Numbers also drift with disease location. Isolated small-bowel Crohn’s disease can sometimes produce lower fecal calprotectin than active colitis, so a value near 80 µg/g does not fully exclude Crohn’s when symptoms include weight loss, anemia, mouth ulcers, or recurrent fevers.
If your report uses an unfamiliar unit or the range looks different from a previous lab, check the assay before comparing results. Our explanation of lab values in different units covers this exact problem in a blood-test setting.
IBD signal versus IBS pattern
IBS usually does not raise fecal calprotectin because IBS is a disorder of gut-brain signaling and bowel sensitivity, not visible inflammatory injury. In adults with classic IBS symptoms, a calprotectin result below 50 µg/g strongly supports a non-inflammatory pathway.
Menees and colleagues found that a fecal calprotectin level of 40 µg/g or lower made IBD very unlikely in patients meeting IBS symptom criteria, with the post-test probability falling to about 1% in many clinical scenarios (Menees et al., 2015). That is why I often reassure patients with normal calprotectin and years of stable IBS-like symptoms.
The tricky group is the patient who has IBS-like cramping but also wakes at 3 a.m. with diarrhea, has visible blood, or has lost 5 kg without trying. Those features are not typical IBS; even a borderline calprotectin deserves a more serious review when red flags travel with it.
IBS and IBD can coexist. I have seen patients with ulcerative colitis in remission, calprotectin under 50 µg/g, and ongoing urgency from post-inflammatory bowel sensitivity; escalating IBD medication in that situation can miss the real problem.
For patients who have normal calprotectin and symptoms driven by food triggers, a structured diet trial can be reasonable. Our patient guide to the low FODMAP diet explains where blood tests help and where they do not.
Infection and short-term gut illness can raise results
Bacterial gastroenteritis, viral enteritis, parasites, and recent food poisoning can temporarily raise fecal calprotectin, sometimes above 200 µg/g. A result taken during or soon after diarrhea should be interpreted as a snapshot of current bowel irritation, not a lifelong IBD label.
Timing is the detail patients rarely receive. After a clear stomach bug, calprotectin may stay raised for 2 to 6 weeks, and I usually avoid over-reading a single test during that recovery window unless the patient is very unwell.
Infection patterns often look abrupt: sudden diarrhea, fever, cramps, travel exposure, sick household contacts, or symptoms after a shared meal. IBD more often shows a relapsing pattern over weeks to months, although first presentations can absolutely look like infection.
A stool culture, ova and parasite test, C. difficile toxin test, or multiplex stool PCR may be more useful than repeating calprotectin immediately if fever, dehydration, or bloody diarrhea is present. Our infection blood test guide explains how CRP, white cells, and procalcitonin can add urgency signals when symptoms are systemic.
One practical rule: do not call a borderline 90 µg/g result IBD if the sample was collected four days after vomiting and diarrhea swept through the family. Recheck after recovery if symptoms continue.
NSAIDs, PPIs and medicines that can muddy the picture
NSAIDs such as ibuprofen, naproxen, and diclofenac can raise fecal calprotectin by irritating the intestinal lining, even in people without IBD. If it is medically safe, clinicians often repeat the test after 2 to 3 weeks off NSAIDs before escalating investigations.
A familiar scenario: a runner takes naproxen for knee pain, develops loose stools, and returns a calprotectin of 140 µg/g. That number is not meaningless, but it is not the same as 140 µg/g in someone with rectal bleeding, low hemoglobin, and no medication trigger.
Aspirin at cardiovascular doses may have a smaller effect than full-dose NSAIDs, but the decision to stop aspirin must never be made casually. If aspirin was prescribed after a heart attack, stroke, stent, or high-risk vascular event, speak with the prescribing clinician before changing anything.
Proton pump inhibitors are more debated. Some studies and clinical series link PPIs with modest calprotectin increases, while other patients show no change; our guide on long-term PPI labs covers the blood markers I watch when reflux medication has been used for months or years.
Antibiotics, immune checkpoint inhibitors, and some chemotherapy regimens can also change bowel inflammation patterns. The safest question is not only what is your number, but what changed in the 4 weeks before the sample.
Blood markers that change how doctors read calprotectin
Fecal calprotectin becomes more concerning when blood tests also show low hemoglobin, raised CRP, raised ESR, low albumin, high platelets, or iron deficiency. The combination of stool inflammation plus systemic inflammation is more persuasive than either result alone.
A calprotectin of 180 µg/g with hemoglobin 14.2 g/dL, CRP 2 mg/L, albumin 43 g/L, and stable weight feels different from 180 µg/g with hemoglobin 9.8 g/dL and CRP 48 mg/L. Same stool number. Very different clinical conversation.
Platelets can be a quiet clue. In active IBD, platelet counts may rise above 400 x 10⁹/L, partly because inflammation and iron deficiency both stimulate platelet production.
Kantesti is an AI-powered blood test analysis tool used by more than 2M people across 127 countries, and our neural network flags clusters such as anemia plus high CRP plus low albumin as follow-up patterns rather than isolated abnormalities. For readers comparing systemic markers, our article on inflammation blood tests explains CRP, ESR, ferritin, fibrinogen, and CBC clues.
CRP is not the same as hs-CRP. If your report lists a cardiac hs-CRP of 3.5 mg/L, do not interpret it like an acute infection CRP of 35 mg/L; our CRP versus hs-CRP guide separates those two results.
When a repeat fecal calprotectin test makes sense
A repeat fecal calprotectin test makes sense for borderline results between 50 and 150 µg/g when symptoms are stable and there are no alarm features. Many clinicians repeat in 2 to 4 weeks, or 4 to 6 weeks after a clear infection has resolved.
Repeating too soon can waste the opportunity. If the first result was raised during a flare of diarrhea, while taking NSAIDs, or immediately after antibiotics, a second sample 5 days later may only repeat the same temporary signal.
Trend direction matters. A fall from 220 to 70 µg/g after stopping NSAIDs and recovering from gastroenteritis is reassuring, while a rise from 90 to 310 µg/g over a month deserves a different level of attention.
I advise patients to repeat under cleaner conditions: no avoidable NSAIDs for 2 to 3 weeks, no active stomach bug, no menstrual contamination, and a sample delivered according to the laboratory’s stability rules. Stool calprotectin is reasonably stable, but delays, heat, and poor collection can still add noise.
The same logic applies to blood tests: abnormal values are often best handled by confirming the pattern, not reacting to a single flag. Our guide to repeating abnormal labs gives timing examples patients can discuss with their clinician.
When to discuss colonoscopy instead of waiting
Colonoscopy discussion is reasonable when fecal calprotectin stays above 250 µg/g, rises on repeat testing, or appears with visible blood, weight loss, anemia, fever, nocturnal diarrhea, or a strong family history. A normal or borderline result should not delay urgent assessment when red flags are present.
Most clinicians do not scope every patient with a calprotectin of 75 µg/g. But a patient aged 58 with new bowel habit change and rectal bleeding needs a cancer-pathway discussion regardless of whether calprotectin is 40 or 240 µg/g.
Colonoscopy is not only about diagnosing IBD. It can assess polyps, colorectal cancer, microscopic colitis, diverticular disease, ischemic colitis, and other causes of lower-gut symptoms that calprotectin cannot distinguish.
The British Society of Gastroenterology guideline for adults with IBD emphasizes objective assessment of disease activity, including biomarkers and endoscopy when needed (Lamb et al., 2019). In plain English: when symptoms, stool markers, and blood markers do not line up neatly, direct visualization sometimes answers what biomarkers cannot.
Unintentional weight loss changes the threshold for action. Our guide to unexplained weight loss lists the blood tests doctors often pair with gut evaluation when appetite, weight, and stools have shifted together.
Children, pregnancy, older adults and exercise caveats
Adult fecal calprotectin ranges should not be copied directly into infants and young children because baseline levels are often higher in early life. Pregnancy, older age, endurance exercise, and recent gastrointestinal procedures can also change how cautiously a result should be read.
Infants can have calprotectin values several times higher than adult cutoffs without having IBD, especially in the first year of life. Pediatric gastroenterologists often interpret the result against age, growth, stool pattern, and feeding history rather than a single adult threshold.
In pregnancy, rectal bleeding is sometimes blamed on hemorrhoids, but persistent diarrhea, anemia, or calprotectin above 250 µg/g deserves proper review. The risk of uncontrolled IBD can be more harmful than carefully selected diagnostic testing.
Older adults need a wider lens. A high result after age 50 may still be IBD or infection, but clinicians also think about colorectal cancer, ischemia, diverticulitis, medication injury, and microscopic colitis.
For parents reading pediatric reports, our pediatric lab ranges guide shows why children’s results often cannot be interpreted with adult cutoffs. The same principle applies to stool inflammation markers.
How I read calprotectin beside blood tests
I read fecal calprotectin beside CBC, CRP, ESR, ferritin, albumin, liver enzymes, and kidney function because intestinal inflammation rarely travels alone when it is clinically significant. A single stool value is useful; a pattern across stool, blood, symptoms, and time is better.
As Thomas Klein, MD, I become more concerned when calprotectin elevation and iron deficiency appear together. A ferritin of 8 ng/mL, hemoglobin 10.5 g/dL, and calprotectin 280 µg/g in a man or postmenopausal woman is not a wait-and-see pattern.
Albumin is another underrated clue. Active intestinal inflammation can lower albumin below 35 g/L through poor intake, protein loss, or systemic inflammation; when low albumin joins high calprotectin, I move faster.
Kantesti AI interprets these blood markers using trend analysis, unit recognition, and rule-based medical safety checks aligned with our medical validation framework. The platform does not diagnose IBD from a stool result, but it can help patients notice when blood patterns make follow-up more urgent.
Slow drift matters more than patients expect. Our article on blood test analytics explains why a hemoglobin slide from 14.1 to 12.0 g/dL over 9 months can matter even if both values once looked acceptable.
Using AI safely with stool and blood results
AI can help organize fecal calprotectin context, but it should not replace a clinician when results are high, persistent, or paired with red-flag symptoms. The safest use is triage support: what might explain the number, what to repeat, and what deserves medical review.
Kantesti AI is an AI biomarker interpretation platform that reads blood test PDFs and photos in about 60 seconds, then places abnormal markers into clinical patterns. If a stool result arrives with blood tests, our platform can help the patient prepare better questions for a gastroenterology or primary-care appointment.
The blind spot is obvious: calprotectin is a stool marker, and no AI should pretend it has seen your colon. Symptoms, examination, stool cultures, imaging, and endoscopy may still be needed when the risk pattern is uncomfortable.
Our engineering team describes the safety architecture behind OCR, unit recognition, reference-range parsing, and clinical guardrails in the technology guide. I prefer AI that says “this needs a doctor” when the pattern is unsafe, rather than AI that gives a neat but false answer.
For a balanced view of strengths and limits, see our guide to AI interpretation. In medicine, a cautious answer is often the honest one.
How to collect the sample without creating noise
A fecal calprotectin sample is most useful when it is collected cleanly, promptly, and away from obvious contamination. Do not mix the stool sample with urine, toilet water, menstrual fluid, or cleaning products, because poor collection can make interpretation less reliable.
Use the container and scoop supplied by the laboratory, and collect from a part of the stool that best represents the episode being tested. If diarrhea is intermittent, sampling on a day with symptoms may be more informative than sampling during a completely normal bowel day.
Refrigeration rules differ. Many calprotectin samples are stable for a few days, but some laboratories require delivery within 24 to 72 hours or refrigeration if there is a delay.
Avoid collecting during heavy menstrual flow if possible, and tell your clinician if bleeding from hemorrhoids, a fissure, or recent rectal procedures could have affected the sample. Small details often explain borderline values better than another web search.
Kantesti AI cannot fix a poorly collected stool sample, but it can help patients track whether blood markers around the same date support or contradict the stool result. Our research-style guide to digestive symptom changes gives practical context for diarrhea timing, stool appearance, and follow-up.
A practical action plan for your result
Use the fecal calprotectin result as a triage tool: below 50 µg/g is usually reassuring, 50 to 150 µg/g often merits repeat testing, 150 to 250 µg/g needs context, and persistent values above 250 µg/g should be discussed with a clinician. Symptoms decide urgency.
If your result is under 50 µg/g and you have long-standing bloating or cramping without weight loss, bleeding, fever, or anemia, ask about IBS management, diet triggers, celiac screening if not done, and medication review. That is a sensible path, not dismissal.
If your result is 50 to 150 µg/g, look for explanations: infection in the last 6 weeks, NSAID use, PPI use, recent travel, antibiotics, or sample contamination. A clean repeat test can prevent an unnecessary procedure and also catch the minority of results that are rising.
If your result is above 250 µg/g or paired with rectal bleeding, nocturnal diarrhea, low hemoglobin, high CRP, or weight loss, book medical review rather than waiting for the number to “settle.” In my practice, persistence and clustering are what move a calprotectin result from interesting to actionable.
Kantesti AI content is reviewed against medical standards with clinician oversight, and our Medical Advisory Board supports that process. A stool marker can start the conversation, but a safe plan still belongs to you and your healthcare professional.
Frequently Asked Questions
What is the fecal calprotectin normal range for adults?
The usual fecal calprotectin normal range for adults is below 50 µg/g of stool, although some laboratories use below 100 µg/g as a reassuring threshold. Results from 50 to 150 µg/g are often called borderline or indeterminate. Values above 250 µg/g are more suggestive of intestinal inflammation and usually deserve clinician review if persistent.
Can IBS cause high fecal calprotectin?
IBS usually does not cause high fecal calprotectin because IBS does not typically involve neutrophil-driven inflammation of the bowel lining. A value below 50 µg/g strongly supports a non-inflammatory pattern in adults with typical IBS symptoms. If calprotectin is above 150 to 250 µg/g, clinicians usually look for IBD, infection, medication injury, diverticulitis, celiac disease, or another inflammatory cause rather than blaming IBS alone.
How high is fecal calprotectin in Crohn’s disease or ulcerative colitis?
Active Crohn’s disease or ulcerative colitis often produces fecal calprotectin above 250 µg/g, and values above 500 µg/g are common in more active colitis. Some severe flares or infections can push results above 1000 µg/g. A lower result does not fully exclude isolated small-bowel Crohn’s disease, so symptoms and blood markers still matter.
Can NSAIDs raise fecal calprotectin?
Yes, NSAIDs such as ibuprofen, naproxen, and diclofenac can raise fecal calprotectin by irritating the intestinal lining. If the result is borderline, many clinicians repeat the test after 2 to 3 weeks off NSAIDs when stopping is medically safe. Aspirin prescribed for heart or stroke prevention should not be stopped without advice from the prescribing clinician.
When should fecal calprotectin be repeated?
Fecal calprotectin is commonly repeated after 2 to 4 weeks for borderline results between 50 and 150 µg/g if there are no red flags. After a clear stomach infection, waiting 4 to 6 weeks can give the bowel time to settle. Repeat sooner only if symptoms worsen or a clinician is concerned about bleeding, dehydration, fever, or significant weight loss.
Does high fecal calprotectin mean I need a colonoscopy?
High fecal calprotectin does not automatically mean you need a colonoscopy, but persistent results above 250 µg/g should prompt a discussion with a clinician. Colonoscopy is more likely to be recommended when high calprotectin appears with blood in stool, anemia, weight loss, fever, night-time diarrhea, or a strong family history. A single borderline result after infection or NSAID use is often handled with repeat testing first.
Can a normal fecal calprotectin miss IBD?
A normal fecal calprotectin below 50 µg/g makes active IBD less likely, but it cannot exclude every case. Isolated small-bowel Crohn’s disease, early disease, intermittent inflammation, or sample timing can occasionally produce lower values. If symptoms include weight loss, anemia, visible blood, persistent fever, or waking at night to pass stool, medical review is still appropriate even with a normal result.
Get AI-Powered Blood Test Analysis Today
Join over 2 million users worldwide who trust Kantesti for instant, accurate lab test analysis. Upload your blood test results and receive comprehensive interpretation of 15,000+ biomarkers in seconds.
📚 Referenced Research Publications
Klein, T., Mitchell, S., & Weber, H. (2026). Clinical Validation Framework v2.0 (Medical Validation Page). Kantesti AI Medical Research.
Klein, T., Mitchell, S., & Weber, H. (2026). AI Blood Test Analyzer: 2.5M Tests Analyzed | Global Health Report 2026. Kantesti AI Medical Research.
📖 External Medical References
⚕️ Medical Disclaimer
This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis and treatment decisions.
E-E-A-T Trust Signals
Experience
Physician-led clinical review of lab interpretation workflows.
Expertise
Laboratory medicine focus on how biomarkers behave in clinical context.
Authoritativeness
Written by Dr. Thomas Klein with review by Dr. Sarah Mitchell and Prof. Dr. Hans Weber.
Trustworthiness
Evidence-based interpretation with clear follow-up pathways to reduce alarm.